APS:CA Aptose Biosciences Inc

CAD 2.24 0.19 9.268293
Icon

Aptose Biosciences Inc (APS:CA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | TSX
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

CAD 2.24

+0.19 (+9.27)%

CAD 0.04B

4.71K

CAD 7.75(+245.98%)

CAD 5.03 (+124.55%)

Icon

APS:CA

Aptose Biosciences Inc (CAD)
COMMON STOCK | TSX
CAD 2.24
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

CAD 0.04B

CAD 5.03 (+124.55%)

CAD 2.24

Aptose Biosciences Inc (APS:CA) Stock Forecast

Show ratings and price targets of :
CAD 7.75
(+245.98%)

Based on the Aptose Biosciences Inc stock forecast from 3 analysts, the average analyst target price for Aptose Biosciences Inc is CAD 7.75 over the next 12 months. Aptose Biosciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Aptose Biosciences Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Aptose Biosciences Inc’s stock price was CAD 2.24. Aptose Biosciences Inc’s stock price has changed by +6.16% over the past week, -9.68% over the past month and -83.41% over the last year.

No recent analyst target price found for Aptose Biosciences Inc
No recent average analyst rating found for Aptose Biosciences Inc

Company Overview Aptose Biosciences Inc

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatmen...Read More

https://www.aptose.com

251 Consumers Road, Toronto, ON, Canada, M2J 4R3

0

December

CAD

Canada

Adjusted Closing Price for Aptose Biosciences Inc (APS:CA)

Loading...

Unadjusted Closing Price for Aptose Biosciences Inc (APS:CA)

Loading...

Share Trading Volume for Aptose Biosciences Inc Shares

Loading...

Compare Performance of Aptose Biosciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for APS:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aptose Biosciences Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
FRX:CA
Fennec Pharmaceuticals Inc +0.29 (+1.96%) CAD0.40B 30.20 -24.62

ETFs Containing APS:CA

Symbol Name APS:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Aptose Biosciences Inc (APS:CA) Stock

Based on ratings from 3 analysts Aptose Biosciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and hold ratings.

Unfortunately we do not have enough data on APS:CA's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for APS:CA is CAD 7.75 over the next 12 months. The maximum analyst target price is CAD 15 while the minimum anlayst target price is CAD 5.

Unfortunately we do not have enough data on APS:CA's stock to indicate if its overvalued.

The last closing price of APS:CA's stock was CAD 2.24.

The most recent market capitalization for APS:CA is CAD 0.04B.

Based on targets from 3 analysts, the average taret price for APS:CA is projected at CAD 7.75 over the next 12 months. This means that APS:CA's stock price may go up by +245.98% over the next 12 months.

We can't find any ETFs which contains Aptose Biosciences Inc's stock.

As per our most recent records Aptose Biosciences Inc has 0 Employees.

Aptose Biosciences Inc's registered address is 251 Consumers Road, Toronto, ON, Canada, M2J 4R3. You can get more information about it from Aptose Biosciences Inc's website at https://www.aptose.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...